FibroTest™ simply involves taking a blood sample from your usual medical test laboratory.
FibroTest evaluates hepatic fibrosis into five stages: from F0 (healthy liver) to F4 (cirrhosis).
In most cases, FibroTest acts as a replacement for a liver biopsy.
The tests target the four main causes of liver disease: fibrosis/cirrhosis (FibroTest™), inflammation (ActiTest™, NashTest™ 2), metabolic conditions (SteatoTest™ 2) and alcohol-related conditions (AshTest™).
NASH-FibroTest™ combines FibroTest, SteatoTest 2 and NashTest 2 along with ActiTest and AshTest into a single blood sample, for patients at risk of NAFLD (Non-Alcoholic Fatty Liver Disease) with or without comorbidities (due to excessive alcohol consumption and hepatitis).
Our research teams are made up of clinicians, statisticians, engineers, and biochemists.
Within an immersive university/hospital environment, they make an active contribution to public health via their first-rate scientific publications.
Our tests are available in medical test laboratories, in downtown locations or in hospitals.
Where to do the testBioPredictive is an independent bio-pharmaceutical company, based in France, which designs and markets diagnostic tests for liver diseases, in particular FibroTest and NASH-FibroTest.
Contact us Twitter FaceBook
